nanotechnology for cancer therapy
Nanotechnology for Cancer Therapy
$219.00 Original price was: $219.00.$4.99Current price is: $4.99. Add to cart
Sale!

Nanotechnology for Cancer Therapy

Original price was: $219.00.Current price is: $4.99.

-98%

Flash Sale: Any ebook for just 4.99 USD only

  • Pay with Any Debit/Credit Card
  • Affordable Prices for Readers
Guaranteed Safe Checkout

The Microscopic Vanguard: Nanotechnology for Cancer Therapy

Standard chemotherapy is a crude, blunt instrument; injecting poison into a vein destroys the entire body in the hope of killing a localized tumor. The future of oncology requires weapons that are mathematically engineered at the atomic level. Nanotechnology for Cancer Therapy is a fiercely advanced, highly technical biomedical engineering manual detailing exactly how to build these microscopic assassins. This volume provides the precise molecular blueprints required to design nanoparticles that hunt, infiltrate, and annihilate cancer cells with zero collateral damage.

Mastering the Liposomal Delivery System

The core philosophy of this text is the stealth infiltration. The authors aggressively detail the mechanics of the nanocarrier. It dictates exactly how bioengineers trap highly toxic chemotherapy (like Doxorubicin) inside a microscopic sphere of fat (a liposome) that is mathematically sized to be too large to leak into healthy tissue, but perfectly sized to slip through the chaotic, broken blood vessels surrounding the tumor.

Navigating Active Tumor Targeting

The book provides a masterclass in molecular homing devices. It dictates the exact chemical pathways for functionalizing the nanoparticle. It rigorously explores how to coat the outside of the microscopic bomb with specific antibodies that act as a GPS, guiding the nanoparticle to physically bind *only* to the surface of the cancer cell, allowing it to inject its lethal payload directly into the malignant cytoplasm.

Frequently Asked Questions (FAQs)

Does this book provide standard IV dosing algorithms for clinical oncology?
No, it is a highly advanced *biomedical engineering, materials science, and nanomedicine textbook* focused entirely on the design and synthesis of next-generation drug delivery systems.

Who is the primary audience?
It is the absolute, mandatory benchtop reference for Bioengineers, Nanotechnologists, Pharmacologists, and Drug Development Scientists.